• Written by: (Investorideas.com newswire, breaking stock market
  • Thu, 12 May 2022
  •   United States

Vancouver, British Columbia - May 12, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) and Skye Bioscience, Inc. (OTCQB: SKYE) announced today that the companies have entered into a definitive agreement with respect to a transaction to be completed by way of a Plan of Arrangement whereby Skye would acquire all of the issued and outstanding shares of Emerald in a share-for-share-transaction.

Cannabis Stock News: Emerald Health Therapeutics (CSE: EMH) Signs Arrangement Agreement with Skye Bioscience